National Biodefence Science Board Teleconference

http://www.hhs.gov/aspr/conferences/nbsb/090814-nbsb-meeting.html

August 14, 2009, from 12:00 P.M. to 2:00 P.M. EDT.

Public Participation

Meetings of the NBSB are open to the public and attendance is welcome. Members of the public may listen to the deliberations of the NBSB by calling 1-866-395-4129, referencing the conference ID "ASPR," and then following the directions of the operator. Members of the public participating by telephone will have an opportunity to provide comment during the meeting. Participants should call in 15 minutes prior to the call and will be asked to provide their name, title, and organization.

FINAL AGENDA

12:00 p.m. - 12:15 p.m. Administrative Matters

Call to Order and Conflict of Interest Rules

CAPT Leigh Sawyer, D.V.M., M.P.H.

Executive Director, National Biodefense Science Board

U.S. Department of Health and Human Services

Opening Remarks

Nicole Lurie, M.D., M.S.P.H. (Invited)

Assistant Secretary for Preparedness and Response

U.S. Department of Health and Human Services

Agenda Overview and Goals

Patricia Quinlisk, M.D., M.P.H.

Chair, National Biodefense Science Board

12:15 p.m. - 12:50 p.m. Updates from U.S. Department of Health and Human Services on H1N1:

H1N1 Situational Update

Daniel B. Jernigan, M.D., M.P.H.

Deputy Director, National Center for Immunization and Respiratory Diseases

Centers for Disease Control and Prevention

H1N1 Vaccines

Robin Robinson, Ph.D.

Director, Biomedical Advanced Research and Development Authority

Office of the Assistant Secretary for Preparedness and Response

H1N1 Vaccine Planning

Jay Butler, M.D.

Program Director, H1N1 Vaccine Task Force

Centers for Disease Control and Prevention

Antivirals

Robin Robinson, Ph.D.

Diagnostics

Daniel B. Jernigan, M.D., M.P.H.

12:50 p.m. - 1:00 p.m. Discussion

1:00 p.m. - 1:15 p.m. Advisory Committee Updates:

Vaccines and Related Biological Products Advisory Committee (VRBPAC)

Norman Baylor (Invited)

Director, Office of Vaccines Research and Review

Food and Drug Administration

National Vaccine Advisory Committee (NVAC)

Bruce Gellin, M.D. (Financing)

Director, National Vaccine Program Office

Office of Public Health and Science

Andrew Pavia, M.D. (Safety Monitoring)

Chair, Subcommittee on Safety, NVAC

Advisory Committee on Immunization Practices (ACIP)

Larry K. Pickering, MD, FAAP

Executive Secretary, Advisory Committee on Immunization Practices

Centers for Disease Control and Prevention

1:15 p.m. - 1:20 p.m. Discussion

1:20 p.m. - 1:40 p.m. Psychological impact of H1N1

Dan Dodgen, Ph.D.

Executive Director, Disaster Mental Health Subcommittee

U.S. Department of Health and Human Services

Discussion

1:40 p.m. - 2:00 p.m. Public Comment and Discussion

2:00 p.m. Wrap Up and Adjourn

Patricia Quinlisk, M.D., M.P.H.

For those of you who have been asking, here's a little blurb about the NBSB (National Biodefense Science Board)

The National Biodefense Science Board (NBSB) was created under the authority of the Pandemic and All-Hazards Preparedness Act, signed into law on December 19, 2006.

The NBSB was established to provide expert advice and guidance to the Secretary of the U.S. Department of Health and Human Services (HHS) on scientific, technical, and other matters of special interest to HHS regarding activities to prevent, prepare for, and respond to adverse health effects of public health emergencies resulting from chemical, biological, nuclear, and radiological events, whether naturally occurring, accidental, or deliberate.

The Board may also provide advice and guidance to the Secretary on other matters related to public health emergency preparedness and response.

(all info on this meeting comes courtesy of SusanC of fluwiki)